IP Verse

Viiv Healthcare Company competitive analysis

Latest patents of Viiv Healthcare Company opposed by its competitors

Explore Viiv Healthcare Company's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3694522
Nov 26, 2025Bi-Layer Pharmaceutical Tablet Formulation2
EP4072520
Sep 24, 2025Pharmaceutical Compositions Comprising Cabotegravir1
EP3494972
Dec 13, 2023Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv Infection9
EP3045206
Feb 15, 2023Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
EP3284520
Jun 5, 2019Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity1
EP3127542
Aug 22, 2018Antiviral Therapy4
EP2932970
Mar 21, 2018Antiviral Therapy2

Latest PTAB cases involving Viiv Healthcare Company

Discover the latest PTAB cases involving Viiv Healthcare Company, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 28, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Viiv Healthcare Company

IPR2015-00550Jan 8, 2015TEVA PHARMACEUTICALSVIIV HEALTHCAREInstitution Denied
IPR2014-00876Jun 2, 2014APOTEXVIIV HEALTHCARETerminated-Settled

Peer Comparison New

IP litigation analysis comparing Viiv Healthcare Company with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
VIIV HEALTHCARE - 20 - 2
COOKE28 - - 4
ELKINGTON AND FIFE102 - - -
TEVA PHARMACEUTICAL INDUSTRIES LTD2104 - -